We recently published a list of Billionaire Israel Englander’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands ...

IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence ...

The vice president and lead of IQVIA's Market Access Center of Excellence says fewer drugs are hitting the $100 million mark ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $227.67, ...

HSBC analyst Sidharth Sahoo downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. The firm adjusted ratings in ...

Fintel reports that on April 25, 2025, HSBC downgraded their outlook for IQVIA Holdings (NYSE:IQV) from Buy to Hold. Analyst ...

The stock's rise snapped a four-day losing streak.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the global independent research and analysis firm ...

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...